Blueprint Medicines Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 7.38, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Blueprint Medicines in Mar 31 2025 quarter, has decreased to 49 days, compared to 51 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 222 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1872, from overall ranking in the fourth quarter 2024 at 2118.

What is Receivable Turnover Ratio?
What is Blueprint Medicines Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BPMC Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	30.04 %	76.98 %	61.07 %	142.01 %	100.11 %
Y / Y Revenue Change	55.45 %	88.19 %	126.61 %	139.98 %	67.25 %
Receivable Turnover Ratio (TTM)	7.38	7.1	6.94	6.44	6.44
BPMC's Total Ranking	# 1872	# 2118	# 1827	# 1729	# 423
Accounts Receivable average collection period days	49	51	53	57	57
Seq. Receivable Change	3.02 %	15.17 %	-22.62 %	41.65 %	40.21 %
Seq. Revenue Change	2.08 %	14.19 %	-7.22 %	43.74 %	23.58 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 72
Healthcare Sector	# 223
Overall Market	# 1872

Receivable Turnover Ratio Statistics
High	Average	Low
69.52	20.41	5.14
(Dec 31 2019)		(Sep 30 2021)

BPMC Company Profile • Back to BPMC Efficiency Comparisons • Compare BPMC Receivables Turnover Ratio to its Competitors

Financial Statements
Blueprint Medicines's Accounts Receivable	$ 78 Millions	Visit BPMC's Balance sheet
Blueprint Medicines's Sales TTM	$ 562 Millions	Visit BPMC's Income Statement
Sources of BPMC's Revenues		Visit BPMC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BPMC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BPMC's Growth Rates	BPMC's Roa	BPMC's Inventory Turnover Ratio	BPMC's Dividend Comparisons
BPMC's Profitability Ratios	BPMC's Roi	BPMC's Asset Turnover Ratio	BPMC's Dividend Growth
BPMC's Valuation Ratios	BPMC's Roe	BPMC's Financial Strength Ratios	BPMC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
Ethema Health Corporation	19.45	$ 8.235 Millions	$ 0.423 Millions
Valion Bio Inc	19.29	$ 0.516 Millions	$ 0.027 Millions
Xoma Royalty Corporation	19.17	$ 42.909 Millions	$ 2.238 Millions
Neuroone Medical Technologies Corp	18.78	$ 6.864 Millions	$ 0.365 Millions
Innovage Holding Corp	17.76	$ 831.684 Millions	$ 46.837 Millions
Talkspace Inc	17.56	$ 193.386 Millions	$ 11.012 Millions
Milestone Scientific Inc	17.43	$ 8.418 Millions	$ 0.483 Millions
Innoviva Inc	17.30	$ 408.353 Millions	$ 23.598 Millions
Neuraxis Inc	17.06	$ 2.935 Millions	$ 0.172 Millions
Novavax inc	17.00	$ 1,254.962 Millions	$ 73.803 Millions
Bellevue Life Sciences Acquisition Corp	16.92	$ 3.381 Millions	$ 0.200 Millions
Pluri Inc	16.81	$ 1.034 Millions	$ 0.062 Millions
Generation Bio Co	15.93	$ 24.556 Millions	$ 1.541 Millions
Petvivo Holdings Inc	15.90	$ 1.133 Millions	$ 0.071 Millions
Zomedica Corp	15.35	$ 27.377 Millions	$ 1.783 Millions
Scienture Holdings Inc	15.32	$ 0.147 Millions	$ 0.010 Millions
Ontrak Inc	15.28	$ 9.890 Millions	$ 0.647 Millions
Quipt Home Medical Corp	15.17	$ 425.431 Millions	$ 28.053 Millions
Kiniksa Pharmaceuticals International Plc	15.14	$ 481.166 Millions	$ 31.782 Millions
China Pharma Holdings Inc	14.95	$ 4.295 Millions	$ 0.287 Millions
Mannkind Corporation	14.48	$ 297.595 Millions	$ 20.559 Millions
Icu Medical Inc	14.25	$ 2,419.911 Millions	$ 169.876 Millions
Inmed Pharmaceuticals Inc	14.25	$ 4.515 Millions	$ 0.317 Millions
Co diagnostics Inc	14.01	$ 3.498 Millions	$ 0.250 Millions
Absci Corp	13.92	$ 4.815 Millions	$ 0.346 Millions
Lipella Pharmaceuticals Inc	13.76	$ 0.520 Millions	$ 0.038 Millions
Biofrontera Inc	13.45	$ 59.599 Millions	$ 4.431 Millions
Dyadic International Inc	13.39	$ 3.554 Millions	$ 0.265 Millions
Lftd Partners Inc	13.23	$ 35.782 Millions	$ 2.704 Millions
Grail Inc	13.17	$ 130.711 Millions	$ 9.925 Millions

Date modified: 2026-09-08T16:52:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.